The biggest thing in diabetes headlines of late is Bydureon, the first and only once-a-week drug to help type 2 diabetics keep their sugars in check, which is newly approved by the FDA. Amylin’s stock price is up, and the pharma blogosphere is all abuzz. But if you’re like us, you may be wondering what the really big deal is. New type 2 drugs come out all the time, don’t they?
Well, for one thing,…
Happy Valentine’s Day! There is nothing quite like the support of a partner in dealing with diabetes, and we’re even more in awe when we see partners “getting their hands dirty” with work in diabetes advocacy. Such is the case with Chris Barnes, husband to Brandy Barnes, the founder of the DiabetesSisters.org community. Brandy has hosted several national conferences for women with diabetes (we attended their Spring conference last year), and Chris has been a…
Read more »
Charles a.k.a. “Chip” Zimliki is a biologist who works at FDA. He’s an important person for all PWDs to know about in that he has a key role in developing the technology that will one day become a functioning Artificial Pancreas. Chip came to FDA as a grad student on fellowship doing pancreatic beta cell research for diabetes, which was always “near and dear to my heart,” he says, as a long-time type 1 diabetic…
Read more »
Who couldn’t use a little sugar-free Valentine’s Day lovin’?
Thanks to T1 blogger and talented illustrator Kim Vlasnik, who knows exactly what female PWDs want. (Sorry guys!)…
Read more »
Diabetes isn’t very loving, but here at the ‘Mine, we’re here to support you! Welcome to another edition of our weekly advice column, Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
Mysteries are all around us in the world of diabetes, and today Wil tackles a couple involving Lantus.
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
Francisco from New Jersey, type 2, writes: I took…